What are the Factors Associated With Short Prostate Specific Antigen Doubling Time After Radical Prostatectomy? A Report From the SEARCH Database Group-Reference-Cited by-同舟云学术

What are the Factors Associated With Short Prostate Specific Antigen Doubling Time After Radical Prostatectomy? A Report From the SEARCH Database Group

Published:2008-11 Issue:5 Volume:180 Page:1980-1985
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Teeter Anna E.¹²,Bañez Lionel L.¹²,Presti Joseph C.³,Aronson William J.⁴⁵,Terris Martha K.⁶,Kane Christopher J.⁷,Amling Christopher L.⁸,Freedland Stephen J.¹²⁹

Affiliation:

1. Division of Urologic Surgery and Duke Prostate Center, Department of Surgery, Duke University Medical Center, Durham, North Carolina

2. Urology Section, Department of Surgery, Veterans Affairs Medical Centers, Durham, North Carolina

3. Department of Urology, Stanford University Medical Center and Urology Section, Department of Surgery, Veterans Affairs Medical Center, Palo Alto, California

4. Department of Urology, Stanford University Medical Center and Urology Section, Department of Surgery, Veterans Affairs Medical Center, West Los Angeles, Los Angeles, California

5. Department of Urology, University of California at Los Angeles Medical Center, Los Angeles, California

6. Urology Section, Division of Surgery, Veterans Affairs Medical Centers and Division of Urologic Surgery, Department of Surgery, Medical College of Georgia, Augusta, Georgia

7. Division of Urology, Department of Surgery, University of California at San Diego Medical Center, San Diego, California

8. Division of Urology, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama

9. Department of Pathology, Duke University School of Medicine, Durham, North Carolina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy;D'Amico;J Natl Cancer Inst,2003

2. Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02;Valicenti;Int J Radiat Oncol Biol Phys,2006

3. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy;Freedland;JAMA,2005

4. Characterization of biochemical recurrence after radical prostatectomy;Molitierno;Urol Int,2006

5. Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era;Lin;Urology,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Event‐free survival after radical prostatectomy according to prostate‐specific membrane antigen‐positron emission tomography and European Association of Urology biochemical recurrence risk groups;BJU International;2022-07-12

2. The Clinical Applications of Serum and Urinary Biomarkers in Prostate Cancer;Société Internationale d’Urologie Journal;2020-10-13

3. Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes;PLoS ONE;2014-07-29

4. Do Nomograms Designed to Predict Biochemical Recurrence (BCR) Do a Better Job of Predicting More Clinically Relevant Prostate Cancer Outcomes than BCR? A Report from the SEARCH Database Group;Urology;2013-07

5. Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy;International Urology and Nephrology;2012-09-29